S0618 E7389 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

Summary

RATIONALE: Drugs used in chemotherapy, such as E7389, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase II trial is studying how well E7389 works in treating patients with metastatic or recurrent head and neck cancer.

Timeline

Start

2006-05

Primary completion

2008-08

Completion

2011-07

Drugs

Indications